Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by X. Wei Meng
In Vivo Anti-Tumor Activity of the PARP Inhibitor Niraparib in Homologous Recombination Deficient and Proficient Ovarian Carcinoma
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Related publications
Radiosensitization by PARP Inhibition in DNA Repair Proficient and Deficient Tumor Cells: Proliferative Recovery in Senescent Cells
Radiation Research
Nuclear Medicine
Radiology
Radiation
Imaging
Biophysics
mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize With PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
PARP Inhibitor Treatment in Ovarian and Breast Cancer
Current Problems in Cancer
Cancer Research
Oncology
Loss of NFBD1/MDC1 Disrupts Homologous Recombination Repair and Sensitizes Nasopharyngeal Carcinoma Cells to PARP Inhibitors
Journal of Biomedical Science
Cell Biology
Pharmacology
Biochemistry
Endocrinology
Clinical Biochemistry
Molecular Biology
Medicine
Metabolism
Diabetes
Targeting Autophagy Potentiates the Anti-Tumor Effect of PARP Inhibitor in Pediatric Chronic Myeloid Leukemia
AMB Express
Applied Microbiology
Biotechnology
Biophysics
Clinical Impact of Somatic Variants in Homologous Recombination Repair-Related Genes in Ovarian High-Grade Serous Carcinoma
Cancer Research and Treatment
Cancer Research
Oncology
RING Domain–deficient BRCA1 Promotes PARP Inhibitor and Platinum Resistance
Journal of Clinical Investigation
Medicine
Suberoylanilide Hydroxamic Acid (SAHA) Enhances Olaparib Activity by Targeting Homologous Recombination DNA Repair in Ovarian Cancer
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
A PARP Inhibitor in Pancreatic Cancer: Enhancement Anti-Tumour Activity of Chemoradiation Therapy Against Pancreatic Cancer?
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
